tiprankstipranks
Trending News
More News >
Suven Pharmaceuticals Ltd. (IN:SUVENPHAR)
:SUVENPHAR
India Market
Advertisement

Suven Pharmaceuticals Ltd. (SUVENPHAR) Financial Statements

Compare
2 Followers

Suven Pharmaceuticals Ltd. Financial Overview

Suven Pharmaceuticals Ltd.'s market cap is currently ₹413.96B. The company's EPS TTM is ₹3.5; its P/E ratio is 102.83; Suven Pharmaceuticals Ltd. is scheduled to report earnings on May 28, 2025, and the estimated EPS forecast is ₹1.59. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 11.98B₹ 10.51B₹ 13.40B₹ 12.90B₹ 9.80B
Gross Profit₹ 8.92B₹ 6.01B₹ 7.55B₹ 7.35B₹ 5.60B
Operating Income₹ 2.98B₹ 4.61B₹ 5.19B₹ 5.42B₹ 4.10B
EBITDA₹ 4.34B₹ 4.68B₹ 6.20B₹ 6.74B₹ 4.57B
Net Income₹ 2.65B₹ 3.00B₹ 4.11B₹ 4.54B₹ 3.62B
Balance Sheet
Cash & Short-Term Investments₹ 2.90B₹ 8.21B₹ 4.87B₹ 5.26B₹ 1.88B
Total Assets₹ 30.32B₹ 22.54B₹ 19.66B₹ 18.30B₹ 14.74B
Total Debt₹ 2.79B₹ 649.96M₹ 703.41M₹ 971.27M₹ 1.43B
Net Debt₹ 1.94B₹ 177.65M₹ 55.38M₹ 525.63M₹ 1.36B
Total Liabilities₹ 11.91B₹ 2.03B₹ 2.31B₹ 3.02B₹ 2.94B
Stockholders' Equity₹ 16.97B₹ 20.51B₹ 17.35B₹ 15.27B₹ 11.81B
Cash Flow
Free Cash Flow₹ 1.32B₹ 3.07B₹ 1.65B₹ 2.55B₹ 2.73B
Operating Cash Flow₹ 2.88B₹ 3.58B₹ 4.51B₹ 3.30B₹ 3.83B
Investing Cash Flow₹ -2.55B₹ -3.62B₹ -1.95B₹ -1.36B₹ -3.11B
Financing Cash Flow₹ 33.20M₹ -138.02M₹ -2.36B₹ -1.56B₹ -765.53M
Currency in INR

Suven Pharmaceuticals Ltd. Earnings and Revenue History

Suven Pharmaceuticals Ltd. Debt to Assets

Suven Pharmaceuticals Ltd. Cash Flow

Suven Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis